Los Angeles Capital Management
IDYA icon

Los Angeles Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Los Angeles Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.09K Hold
217
– – ﹤0.01% 2012
2026
Q1 		$7.23K Sell
217
-43
-17% -$1.44K ﹤0.01% 2024
2025
Q4 		$8.22K Buy
+260
New +$8.29K ﹤0.01% 2144
2023
Q4 		– Sell
-18,802
Closed -$507K – 1180
2023
Q3 		$507K Buy
18,802
+456
+2% +$11.6K ﹤0.01% 822
2023
Q2 		$431K Buy
+18,346
New +$377K ﹤0.01% 898

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Los Angeles Capital Management's IDYA Position: Q2 2026 in Review

Los Angeles Capital Management held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 217 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Los Angeles Capital Management first reported a position in IDYA in Q2 2023 and has held it in 5 quarters since. The position peaked at $507K in Q3 2023. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Los Angeles Capital Management held 217 shares of IDEAYA Biosciences worth $8.09K as of Q2 2026.
  • Los Angeles Capital Management left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2012 holding.
  • Los Angeles Capital Management first reported a position in IDEAYA Biosciences in Q2 2023 and has held it in 5 quarters since.
  • Los Angeles Capital Management's IDEAYA Biosciences position peaked at $507K in Q3 2023.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.